Macular Degenerative Disease
Conditions
Keywords
Carotenoids, Macular degeneration, MacuHealth
Brief summary
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Interventions
OTHERLutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Sponsors
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
MacuHealth
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)
Masking description
Placebo vs. Vitamin will be masked to patient and investigator
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Adult patients 18-50 years old of any sex and any race. * Willing to comply with the protocol instructions. * Has read (or has had read to), understood, and signed an Informed Consent.
Exclusion criteria
* Current Smoker * Pregnant, plan to become pregnant or breastfeeding * History of any non-controlled disease states including diabetes, cancer, heart diseases ETC (we need to confirm this with previous protocols) BMI greater than 30 * Currently taking MacuHealth or similar supplements or previous use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Carotenoid concentration | 6 months | Change in skin carotenoid concentration over supplementation vs. placebo exposure durations. |
Countries
United States
Contacts
CONTACTCrystal Remington, OD
CONTACTRyan Powell, OD
Outcome results
None listed